MADD Protein

Migration, Crosslink

📖

MADD Protein

active

wiki page Created: 2026-04-02T07:19:13 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-proteins-madd-protein

📖 Wiki Page

protein1331 wordssynced 2026-04-02

MADD Protein

MADD (MAP3K14 Associated Death Domain Protein) Protein

<div class="infobox infobox-protein">
<div class="infobox-header">MADD (MAP3K14 Associated Death Domain Protein)</div>

<div class="infobox-content">
<div class="infobox-row"><span class="infobox-label">Gene</span><span class="infobox-value">[MADD](/genes/madd) (also SPECD1)</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt ID</span><span class="infobox-value">[Q8TDR2](https://www.uniprot.org/uniprot/Q8TDR2)</span></div>
<div class="infobox-row"><span class="infobox-label">PDB Structures</span><span class="infobox-value">2J7Q, 5MCK, 6GRL</span></div>
<div class="infobox-row"><span class="infobox-label">Molecular Weight</span><span class="infobox-value">95 kDa (836 amino acids)</span></div>
<div class="infobox-row"><span class="infobox-label">Subcellular Localization</span><span class="infobox-value">Cytoplasm, Golgi apparatus, Mitochondria</span></div>
<div class="infobox-row"><span class="infobox-label">Protein Family</span><span class="infobox-value">Death domain family, DENN domain proteins</span></div>
<div class="infobox-row"><span class="infobox-label">Expression</span><span class="infobox-value">High in brain, heart, lung</span></div>
<div class="infobox-row"><span class="infobox-label">Diseases</span><span class="infobox-value">[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)</span></div>
</div>
</div>

Overview

...

MADD Protein

MADD (MAP3K14 Associated Death Domain Protein) Protein

<div class="infobox infobox-protein">
<div class="infobox-header">MADD (MAP3K14 Associated Death Domain Protein)</div>

<div class="infobox-content">
<div class="infobox-row"><span class="infobox-label">Gene</span><span class="infobox-value">[MADD](/genes/madd) (also SPECD1)</span></div>
<div class="infobox-row"><span class="infobox-label">UniProt ID</span><span class="infobox-value">[Q8TDR2](https://www.uniprot.org/uniprot/Q8TDR2)</span></div>
<div class="infobox-row"><span class="infobox-label">PDB Structures</span><span class="infobox-value">2J7Q, 5MCK, 6GRL</span></div>
<div class="infobox-row"><span class="infobox-label">Molecular Weight</span><span class="infobox-value">95 kDa (836 amino acids)</span></div>
<div class="infobox-row"><span class="infobox-label">Subcellular Localization</span><span class="infobox-value">Cytoplasm, Golgi apparatus, Mitochondria</span></div>
<div class="infobox-row"><span class="infobox-label">Protein Family</span><span class="infobox-value">Death domain family, DENN domain proteins</span></div>
<div class="infobox-row"><span class="infobox-label">Expression</span><span class="infobox-value">High in brain, heart, lung</span></div>
<div class="infobox-row"><span class="infobox-label">Diseases</span><span class="infobox-value">[Alzheimer's Disease](/diseases/alzheimers-disease), [Parkinson's Disease](/diseases/parkinsons-disease)</span></div>
</div>
</div>

Overview

MADD (also known as SPECD1, DENN Domain-containing protein) is a 836-amino acid signaling adaptor protein that plays dual roles in both cell survival and apoptotic pathways. Originally identified as a MAP3K14 (NIK) associated death domain protein, MADD has emerged as a critical regulator of TNF receptor signaling, neuronal apoptosis, and synaptic function. Genome-wide association studies (GWAS) have identified MADD as a significant risk gene for Alzheimer's disease, establishing its relevance to neurodegenerative processes[@schneider2023][@li2022].

MADD is highly expressed in the central nervous system, particularly in hippocampal neurons, cortical pyramidal cells, and dopaminergic neurons of the substantia nigra. The protein contains multiple functional domains including an N-terminal DENN domain, central proline-rich regions, and a C-terminal death domain, enabling diverse protein-protein interactions that regulate both pro-survival NF-κB signaling and apoptotic cascade activation.

Structure

MADD possesses a complex multi-domain architecture that underlies its diverse functional capabilities:

Domain Architecture

| Domain | Position (AA) | Function |
|--------|---------------|----------|
| DENN Domain | 1-180 | GEF activity, regulates Rab GTPases and membrane trafficking |
| Proline-Rich Region | 200-400 | SH3 domain interactions, signaling complex scaffolding |
| Coiled-Coil Domain | 400-600 | Protein oligomerization, membrane association |
| Death Domain | 700-836 | TNF receptor interaction, apoptosis signaling |

Structural Features

DENN Domain: The Diffuse B-cell Non-Hodgkin's Lymphoma (DNPR) / Evolutionarily Conserved Signaling Intermediate in Toll Pathways (ECSIT) region confers guanine nucleotide exchange factor (GEF) activity, allowing MADD to regulate Rab GTPases involved in synaptic vesicle trafficking and autophagy
Death Domain: The C-terminal death domain shares structural homology with other death domain proteins (FADD, TRADD) and mediates interactions with TNF receptor superfamily members
Multiple Phosphorylation Sites: MADD is phosphorylated at several residues (Ser71, Thr233, Ser389), regulating its pro-survival versus pro-apoptotic functions

Structural studies have resolved the death domain (PDB: 2J7Q) and portions of the DENN domain (PDB: 5MCK), revealing the molecular basis for protein-protein interactions[@huang2018].

Normal Function

Apoptosis Regulation

MADD functions as a bidirectional regulator of programmed cell death:

TNF Receptor Signaling: MADD binds to TNF receptor 1 (TNFR1), Fas receptor (CD95), and DR6, mediating both survival and death signals depending on cellular context
Caspase Activation: MADD can recruit and activate caspase-8 and caspase-9, initiating the extrinsic and intrinsic apoptotic pathways
Survival Signaling: Under certain conditions, MADD also activates NF-κB and MAPK pathways that promote cell survival

Cell Survival Pathways

NF-κB Activation: MADD interacts with TRAF proteins to activate the NF-κB pathway, promoting expression of anti-apoptotic genes including Bcl-2, c-FLIP, and XIAP
MAPK Signaling: MADD modulates ERK, JNK, and p38 signaling pathways affecting neuronal stress responses
PI3K-AKT Pathway: Cross-talk with survival signaling through AKT phosphorylation

Endocytosis and Synaptic Function

Synaptic Vesicle Trafficking: MADD regulates synaptic vesicle pool dynamics through Rab GTPase interactions
Axonal Transport: MADD associates with microtubule-based motor proteins for organelle transport
Synaptic Plasticity: Modulates long-term potentiation (LTP) and memory formation through NMDA receptor interactions

Cellular Localization

In neurons, MADD exhibits both cytoplasmic and membrane-associated localization:

Cytosolic pools near the Golgi apparatus
Mitochondrial association under stress conditions
Synaptic membrane fractions
Nuclear localization in some contexts

Role in Neurodegeneration

Alzheimer's Disease

MADD is a significant Alzheimer's disease risk gene identified through GWAS, with multiple mechanisms contributing to AD pathogenesis:

APP Processing and Amyloid Generation

Direct APP Interaction: MADD physically interacts with amyloid precursor protein (APP), affecting its processing
BACE1 Modulation: MADD influences beta-secretase (BACE1) activity and APP cleavage
Gamma-Secretase Effects: Alters gamma-secretase complex assembly and activity
Aβ-Induced Toxicity: MADD expression is upregulated in response to amyloid-beta exposure, potentially as a compensatory mechanism

Tau Pathology

Kinase Activation: MADD promotes tau phosphorylation through GSK-3β and CDK5 activation
Phosphorylation Sites: Enhances phosphorylation at AD-relevant epitopes (Ser202, Thr231, Ser396)
Tau Aggregation: May facilitate tau oligomer formation and spreading

Neuronal Apoptosis

TNF-Mediated Death: MADD sensitizes neurons to TNF-alpha-induced apoptosis, a pathway highly relevant to neuroinflammation in AD
Mitochondrial Pathway: Regulates cytochrome c release and caspase-9 activation
Synaptic Loss: Contributes to dendritic spine elimination and synaptic dysfunction
Neuroinflammation: Amplifies inflammatory responses through NF-κB dysregulation[@li2022][@kumar2022]

Parkinson's Disease

MADD contributes to PD pathogenesis through several mechanisms:

Dopaminergic Neuron Survival

TNF-α Toxicity: MADD mediates TNF-induced death in dopaminergic neurons
α-Synuclein Interaction: MADD expression is altered by alpha-synuclein pathology
Mitochondrial Dysfunction: Links to PINK1/Parkin mitophagy pathways
Autophagy Impairment: Affects protein clearance mechanisms[@park2017]

Genetic Association

PD-associated MADD variants have been identified in GWAS
Expression changes in PD brains suggest involvement in disease progression
Interaction with other PD risk genes (LRRK2, GBA, PARK2)

Amyotrophic Lateral Sclerosis (ALS)

MADD is upregulated in ALS motor neurons
Contributes to excitotoxicity-mediated cell death
Links to TDP-43 pathology

Therapeutic Targeting

MADD represents a therapeutic target with both challenges and opportunities:

Strategies

Protein-Protein Interaction Inhibitors: Block MADD death domain interactions with TNF receptors

Phosphorylation Modulators: Target kinases that phosphorylate MADD

Gene Expression Modulation: Antisense oligonucleotides or CRISPR approaches

Small Molecule Modulators: Allosteric modulators of MADD signaling

Challenges

Dual Functionality: MADD has both pro-survival and pro-apoptotic functions
Brain Penetration: Therapeutic molecules must cross the blood-brain barrier
Neuronal Specificity: Targeting neuronal MADD without affecting other tissues

Biomarkers

CSF MADD levels as a potential biomarker
Genetic variants for risk stratification
MADD expression as a therapeutic response marker

Key Publications

[MADD/SPECD1 and Alzheimer's Disease Risk (2023)](https://doi.org/10.1038/s41380-023-01998-6). Molecular Psychiatry. GWAS identification of MADD as AD risk gene.

[MADD in Neuronal Apoptosis (2022)](https://doi.org/10.1016/j.neurobiolaging.2022.03.012). Neurobiology of Aging. Comprehensive review of apoptosis mechanisms.

[Genetic Variants of MADD and PD Risk (2021)](https://doi.org/10.1007/s00415-021-10456-7). Journal of Neurology. PD genetic association.

[MADD mediates TNF-alpha induced neuronal apoptosis (2019)](https://doi.org/10.1038/s41418-019-0347-6). Cell Death & Differentiation.

[MADD interacts with APP processing pathways (2018)](https://doi.org/10.3233/JAD-170891). J Alzheimer's Disease.

[MADD regulates NF-κB signaling in neurons (2020)](https://doi.org/10.1007/s12035-020-01892-6). Molecular Neurobiology.

[MADD and alpha-synuclein toxicity (2017)](https://doi.org/10.1016/j.nbd.2017.04.012). Neurobiology of Disease.

[MADD in synaptic function (2019)](https://doi.org/10.1007/s10571-019-00677-9). Cellular and Molecular Neurobiology.

Cross-References

[MADD Gene](/genes/madd)
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Apoptosis Mechanisms](/mechanisms/apoptosis)
[Tau Protein](/proteins/tau-protein)
[APP Protein](/proteins/app-protein)
[NF-κB Signaling](/mechanisms/nf-kb-signaling)
[Alpha-Synuclein](/proteins/alpha-synuclein)

External Links

[UniProt: Q8TDR2](https://www.uniprot.org/uniprot/Q8TDR2)
[PDB structures](https://www.rcsb.org/search?q=uniprot:Q8TDR2)
[GeneCards: MADD](https://www.genecards.org/cgi-bin/carddisp.pl?gene=MADD)
[PubMed: MADD neurodegeneration](https://pubmed.ncbi.nlm.nih.gov/?term=MADD+Alzheimer+Parkinson)

References

[Schneider J, Kaus C, Weber J, et al., MADD/SPECD1 and Alzheimer's Disease Risk (2023)](https://doi.org/10.1038/s41380-023-01998-6)

[Li X, Wang H, Sun Z, et al., MADD in Neuronal Apoptosis and Neurodegeneration (2022)](https://doi.org/10.1016/j.neurobiolaging.2022.03.012)

[Chen Y, Zhou J, Liu Y, et al., Genetic Variants of MADD and Parkinson's Disease Risk (2021)](https://doi.org/10.1007/s00415-021-10456-7)

[Mueller AM, Yoon BH, Sastry N, et al., MADD mediates TNF-alpha induced neuronal apoptosis (2019)](https://doi.org/10.1038/s41418-019-0347-6)

[Huang J, Liu C, Duan S, et al., MADD interacts with APP processing pathways (2018)](https://doi.org/10.3233/JAD-170891)

[Wang Q, Li L, Zhang H, et al., MADD regulates NF-κB signaling in neurons (2020)](https://doi.org/10.1007/s12035-020-01892-6)

[Park J, Lee J, Kim M, et al., MADD and alpha-synuclein toxicity (2017)](https://doi.org/10.1016/j.nbd.2017.04.012)

[Zhang W, Wang L, Fan Q, et al., MADD in synaptic function and axonal transport (2019)](https://doi.org/10.1007/s10571-019-00677-9)

[Liu J, Zhao Y, Wu Z, et al., MADD variants and cognitive decline in aging (2021)](https://doi.org/10.1111/acel.13345)

[Kumar P, Jha NK, Jha S, et al., MADD and tau phosphorylation in AD models (2022)](https://doi.org/10.1038/s41420-022-00958-7)

📖 View canonical wiki page →

Related Entities

MADDPROTEIN

▸Metadataorigin_type: v1_polymorphic_backfill

slug	proteins-madd-protein
kg_node_id	MADDPROTEIN
entity_type	protein
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-ba1c148953b6
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'proteins-madd-protein'}
_schema_version	1

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

50%

Debates

0

Incoming

10

Outgoing

12

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

MADD Protein

MADD Protein

MADD (MAP3K14 Associated Death Domain Protein) Protein

Overview

MADD Protein

MADD (MAP3K14 Associated Death Domain Protein) Protein

Overview

Structure

Domain Architecture

Structural Features

Normal Function

Apoptosis Regulation

Cell Survival Pathways

Endocytosis and Synaptic Function

Cellular Localization

Role in Neurodegeneration

Alzheimer's Disease

APP Processing and Amyloid Generation

Tau Pathology

Neuronal Apoptosis

Parkinson's Disease

Dopaminergic Neuron Survival

Genetic Association

Amyotrophic Lateral Sclerosis (ALS)

Therapeutic Targeting

Strategies

Challenges

Biomarkers

Key Publications

Cross-References

See Also

External Links

References

💬 Discussion